Clinical Intervention:Molecular Targeted Drugs

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-7 of 7 total displayed.

Most recent content

Research Articles: Therapeutics, Targets, and Development
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes

Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, and Clinton J. Grubbs
Mol. Cancer Ther. 2008; 7: 972-979. [Abstract] [Full text] [PDF]  

Past content

Research Articles
Urinary 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine in Patients with Parasite Infection and Effect of Antiparasitic Drug in Relation to Cholangiocarcinogenesis

Raynoo Thanan, Mariko Murata, Somchai Pinlaor, Paiboon Sithithaworn, Narong Khuntikeo, Walaluk Tangkanakul, Yusuke Hiraku, Shinji Oikawa, Puangrat Yongvanit, and Shosuke Kawanishi
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 518-524. [Abstract] [Full text] [PDF]  

Research Articles
Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations

Joel M. Reid, Sumithra J. Mandrekar, Elsa C. Carlson, W. Scott Harmsen, Erin M. Green, Renee M. McGovern, Eva Szabo, Matthew M. Ames, Daniel Boring, Paul J. Limburg for the Cancer Prevention Network
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 674-679. [Abstract] [Full text] [PDF]  

Cancer Prevention
Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Jeffrey N. Weitzel, Saundra S. Buys, William H. Sherman, Anna Marie Daniels, Giske Ursin, John R. Daniels, Deborah J. MacDonald, Kathleen R. Blazer, Malcolm C. Pike, and Darcy V. Spicer
Clin. Cancer Res. 2007; 13: 654-658. [Abstract] [Full text] [PDF]  

Cancer Susceptibility and Prevention
Effect of Raloxifene on the Incidence of Invasive Breast Cancer in Postmenopausal Women with Osteoporosis Categorized by Breast Cancer Risk

Marc E. Lippman, Steven R. Cummings, Damon P. Disch, John L. Mershon, Sherie A. Dowsett, Jane A. Cauley, and Silvana Martino
Clin. Cancer Res. 2006; 12: 5242-5247. [Abstract] [Full text] [PDF]  

Cancer Prevention
Effects of Long-term Rofecoxib on Gastric Intestinal Metaplasia: Results of a Randomized Controlled Trial

Wai K. Leung, Enders K.W. Ng, Francis K.L. Chan, Wing Y. Chan, Kui-fat Chan, Alex C.M. Auyeung, Candice C.H. Lam, James Y.W. Lau, and Joseph J.Y. Sung
Clin. Cancer Res. 2006; 12: 4766-4772. [Abstract] [Full text] [PDF]  

Special Lecture
Reducing the "Risk" of Chemoprevention: Defining and Targeting High Risk—2005 AACR Cancer Research and Prevention Foundation Award Lecture

Scott M. Lippman and J. Jack Lee
Cancer Res. 2006; 66: 2893-2903. [Abstract] [Full text] [PDF]